Dr Agarwals Health Care Ltd (AGARWALEYE)
₹509.20
Mkt cap
₹16,144 Cr
P/E ratio
109.00
P/B
7.97
Div yield
0.00%
ROE
5.99%
ROCE
10.90%
EPS (TTM)
₹4.67
Book value
₹64
52W range
401–568
Sector
Healthcare
Price history
Previous close
Incorporated in 2010, [1] Dr. Agarwal’s Health Care offers a wide array of eye care services, which include cataract and refractive surgeries, consultations, diagnoses, and non-surgical treatments. Additionally, they provide optical products, contact lenses, accessories, and pharmaceutical items related to eye care. [2]
NSE AGARWALEYEBSE 544350
Health check
Mixed
ValuationExpensive
ProfitabilityWeak
GrowthHigh
TechnicalsBullish
52-week range
−10.31% from high₹509
₹401+26.98% from low₹568
Current
₹509.20
Prev close
₹488.70
Day
+4.19%
Price performance
1D
+3.56%
1W
+6.79%
1M
+2.19%
3M
+4.96%
6M
+14.50%
1Y
−6.64%
YTD
+1.44%
Financials
Revenue, profit & margin
P/E ratio
109.0×
AGARWALEYE is 146% above the sector median of 44.4×
AGARWALEYE109.0×
Sector median44.4×
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 333 | 349 | 403 | 417 | 431 | 460 | 487 | 499 | 530 | 564 | 614 | |
| Expenses | 244 | 241 | 300 | 310 | 316 | 329 | 360 | 363 | 386 | 403 | 444 | |
| Operating Profit | 89 | 108 | 104 | 107 | 115 | 131 | 128 | 136 | 144 | 161 | 170 | |
| OPM % | 27% | 31% | 26% | 26% | 27% | 28% | 26% | 27% | 27% | 29% | 28% | |
| Other Income | 12 | 20 | 6 | 12 | 13 | 13 | 13 | 8 | 11 | 14 | 6 | |
| Interest | 22 | 27 | 27 | 28 | 28 | 25 | 25 | 23 | 21 | 22 | 23 | |
| Depreciation | 43 | 47 | 56 | 57 | 58 | 60 | 63 | 68 | 69 | 77 | 78 | |
| Profit before tax | 36 | 54 | 27 | 33 | 41 | 59 | 54 | 54 | 65 | 77 | 75 | |
| Tax % | 37% | 24% | 33% | 36% | 31% | 27% | 29% | 32% | 33% | 35% | 27% | |
| Net Profit | 23 | 41 | 18 | 21 | 28 | 43 | 38 | 36 | 44 | 50 | 55 | |
| EPS in Rs | 0.72 | 1.03 | 0.95 | 0.94 | 1.07 | 1.25 | 1.43 | |||||
| Raw PDF |
Earnings
Results dates & reactionsNext results
5 Nov '26
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move −0.10% · closed higher next day 3 of last 7
| Q3FY25 | Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 | |
|---|---|---|---|---|---|---|---|
| Broadcast | 15 Feb '25◦ | 29 May '25 | 12 Aug '25◦ | 30 Oct '25◦ | 3 Feb '26◦ | 21 May '26◦ | 4 Aug '26◦ |
| Earnings day | −3.26% | −1.64% | +0.41% | −2.44% | +1.04% | −0.36% | +5.58% |
| +1 day | −5.06% | −4.07% | +4.29% | −0.06% | +2.41% | −0.29% | +7.86% |
| +5 days | −8.31% | +0.47% | +1.26% | −3.04% | +2.71% | +0.05% | +3.64% |
| +15 days | −4.31% | +15.60% | −5.36% | −2.37% | +1.23% | −8.69% | +1.02% |
| +30 days | −0.69% | +23.81% | +8.72% | −4.03% | −4.98% | −1.78% | +1.35% |
| Filing | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Sep 202632.33%Promoter
Promoters32.33%0.01
FIIs49.56%8.41
DIIs15.86%8.14
Public2.23%0.26
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | ₹8,448.00 | 57.74 | 1,21,469 | 0.24% | 610 | +34.17% | 7,044 | +20.56% | 17.45% |
| Manipal Health | ₹669.15 | 99.41 | 88,018 | 0.00% | 243 | −7.86% | 3,091 | +38.12% | 12.10% |
| Max Healthcare | ₹860.00 | 58.93 | 83,705 | 0.23% | 414 | −15.54% | 2,569 | +20.31% | 14.71% |
| Aster DM Quality | ₹681.15 | 164.50 | 59,374 | 0.44% | 29 | −46.12% | 1,311 | +21.60% | 11.57% |
| Fortis Health. | ₹768.15 | 54.36 | 57,992 | 0.13% | 273 | +3.39% | 2,545 | +17.46% | 13.45% |
| Narayana Hrudaya | ₹1,720.20 | 38.85 | 35,154 | 0.26% | 301 | +16.61% | 2,844 | +73.01% | 15.50% |
| Global Health | ₹1,270.30 | 59.66 | 34,156 | 0.04% | 157 | −0.18% | 1,304 | +26.50% | 17.37% |
| Dr Agarwal's Hea | ₹509.20 | 109.32 | 16,144 | 0.00% | 55 | +50.52% | 614 | +25.97% | 10.90% |
| Median: 31 Co. | ₹509.20 | 44.38 | 6,363 | 0.00% | 30 | +17.80% | 403 | +22.28% | 14.62% |
Filings
Annual reports2
Concall transcripts21
Credit ratings6
Announcements5
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 23 Oct - Board meeting on November 5, 2026 to approve Q2/H1 FY27 results; earnings call at 6:30 PM IST.Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended September 30, 2026 23 Oct - Board meeting on November 5, 2026 to approve Q2 and half-year FY26 results; analyst call at 6:30 PM.Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 20 Oct - Allotment of 18,200 Equity Shares pursuant to the exercise of options granted under Dr. Agarwal''s Health Care Limited - Employees Stock Option Scheme 2022Fixation Of Record Date W.R.T. The Scheme Of Amalgamation Between Dr. Agarwals Eye Hospital Limited And Dr. Agarwals Health Care Limited 20 Oct - NCLT-sanctioned amalgamation effective November 1, 2026; record date November 18, 2026 for share exchange.Board Meeting Outcome for Material Update On The Scheme Of Amalgamation Between Dr. Agarwal''s Eye Hospital Limited And Dr. Agarwal''s Health Care Limited And Their Respective Shareholders And Creditors 20 Oct - NCLT-sanctioned amalgamation becomes effective Nov 1, 2026; record date Nov 18 for 23:2 share exchange.